Allogene Therapeutics, Inc. ($ALLO)
Filing Information
| Accession Number | 0001737287-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 4, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
715,553
Total Value
$42,241.76
P&L
+inf% (+$1,431,512.64)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF FINANCIAL OFFICER | Common Stock | โ | Feb 2, 2026 | Sale | 24,001 | $1.76 | $42,241.76 | 1,252,795 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Stock Option (Right to buy) | Derivative | Feb 2, 2026 | Grant/Award | 539,072 | $0.00 | $0.00 | 539,072 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Restricted Stock Unit | Derivative | Feb 2, 2026 | Grant/Award | 152,480 | $0.00 | $0.00 | 152,480 | Direct | โ | View Details |